This activation results in a greater production of inflammatory cytokines, such as TNFα and IL-6, inducing an inflammatory state in the liver, which is a well-known contributor to the development and/or progression of NAFLD [71] (Figure 1). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.